Related references
Note: Only part of the references are listed.A Review of Modern Computational Algorithms for Bayesian Optimal Design
Elizabeth G. Ryan et al.
INTERNATIONAL STATISTICAL REVIEW (2016)
Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy
Luc J. Huurneman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Utility of voriconazole therapeutic drug monitoring: a meta-analysis
Me-Linh Luong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients-an evidence-based approach
Meinolf Karthaus et al.
ANNALS OF HEMATOLOGY (2015)
Achieving Target Voriconazole Concentrations More Accurately in Children and Adolescents
Michael Neely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Application of the Optimal Design Approach to Improve a Pretransplant Drug Dose Finding Design for Ciclosporin
Stefanie Hennig et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
A generalisation of T-optimality for discriminating between competing models with an application to pharmacokinetic?studies
Pavan Vajjah et al.
PHARMACEUTICAL STATISTICS (2012)
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Michael Neely et al.
CLINICAL INFECTIOUS DISEASES (2010)
Active Estimation for Jump Markov Linear Systems
Lars Blackmore et al.
IEEE TRANSACTIONS ON AUTOMATIC CONTROL (2008)
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model
D Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Share Paper
